Is acute myeloid leukaemia maintenance therapy necessary?
Lancet Haematol
.
2022 Mar;9(3):e177-e178.
doi: 10.1016/S2352-3026(22)00047-3.
Authors
Farhad Ravandi
1
,
Jeffrey Lancet
2
Affiliations
1
Department of Leukemia, The University of Texas-MD Anderson Cancer Center, Houston, TX, USA. Electronic address: fravandi@mdanderson.org.
2
Moffitt Cancer Center, Tampa, FL, USA. Electronic address: jeffrey.lancet@moffitt.org.
PMID:
35240073
DOI:
10.1016/S2352-3026(22)00047-3
No abstract available
MeSH terms
Cytarabine
Humans
Leukemia, Myeloid, Acute* / drug therapy
Substances
Cytarabine